Pain gas may rob sickle cell kids of key vitamin

NCT ID NCT06581900

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study follows 29 children with sickle cell disease who receive MEOPA gas for pain during a crisis. Researchers will check their vitamin B12 levels before and after treatment, and again at 7 days and 1 month. The goal is to see how often MEOPA causes a B12 deficiency and whether some children are more at risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MEOPA (a medical gas used for pain and sedation)
What this could lead to
If it works, this could help doctors understand which children are at risk of vitamin B12 deficiency from MEOPA and how to prevent it.
What could go wrong
This is a small, early observational study with only 29 children, so results may not apply to everyone. It is not testing a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chu Reims

    RECRUITING

    Reims, 51092, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.